VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: A Wisconsin Oncology Network study

  • Julie E. Chang
  • , Christopher Peterson
  • , Sangbum Choi
  • , Jens C. Eickhoff
  • , Kyungmann Kim
  • , David T. Yang
  • , Leslie A. Gilbert
  • , Eric S. Rogers
  • , Jae E. Werndli
  • , Michael S. Huie
  • , Thomas A. Mcfarland
  • , Michael Volk
  • , Jules Blank
  • , Natalie S. Callander
  • , Walter L. Longo
  • , Brad S. Kahl

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)190-197
Number of pages8
JournalBritish Journal of Haematology
Volume155
Issue number2
DOIs
StatePublished - Oct 2011

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • Bortezomib
  • Chemotherapy
  • Mantle cell lymphoma
  • Non-Hodgkin lymphoma
  • Rituximab

Cite this